Published online before print December 12, 2005, doi: 10.1161/01.HYP.0000196269.98463.fd
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:22.)
© 2006 American Heart Association, Inc.
Original Articles |
The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends
From the Departments of Medicine and Pharmacology and Therapeutics (N.C.), University of Calgary, Calgary; Institute for Clinical Evaluative Sciences (K.T., M.D.), Toronto; University Health Network–Toronto Western Hospital Family Medicine Centre (K.T.), University of Toronto, Toronto; Department of Family and Community Medicine-Family Healthcare Research Unit (K.T.), University of Toronto; Department of Statistics and Centre for Community Child Health Research (R.B.), Child and Family Research Institute, Vancouver; Division of General Internal Medicine (F.M.), University of Alberta, Edmonton, Canada.
Correspondence to Finlay McAlister, 2E3.24 Walter Mackenzie Centre, University of Alberta Hospital, 8440 112 St, Edmonton, Alberta T6G 2R7, Canada. E-mail Finlay.McAlister{at}ualberta.ca
Although previous studies have shown that hypertension management has improved in Canada during the past decade, this study was designed to determine whether these changes were temporally related to initiation of the Canadian Hypertension Education Program in 1999. Antihypertensive prescription rates in Ontario were compared using time series analyses before and after 1999 in 2 Ontario cohorts: all hypertensives prescribed therapy (using the Intercontinental Medical Statistics CompuScript Database) and all elderly hypertensives without diabetes prescribed therapy (using linked administrative databases including the Ontario Drug Benefit Database). Between January 1998 and December 2003, &280 million prescriptions for antihypertensive agents were filled in Ontario, and total antihypertensive prescriptions increased by 58% annually; time series analyses confirmed that the prescribing rates for total antihypertensives, thiazide diuretics, ß-blockers, and calcium channel blockers increased significantly after 1999, even after adjustment for the temporal trends in the pre-1999 data. In the 166 018 nondiabetic individuals over age 65 who were newly treated for hypertension in Ontario between July 1994 and March 2002, changes in prescription rates for total antihypertensive drugs, angiotensin-converting enzyme inhibitors, ß blockers, and calcium channel blockers occurred in directions that were consistent with guideline recommendations and were statistically significantly related to the initiation of the Canadian Hypertension Education Program. The substantial changes in prescription rates for guideline-recommended antihypertensive drug classes in elderly Ontarians without diabetes and the general Ontario population seen in the past decade are temporally related to the initiation of the Canadian Hypertension Education Program.
Key Words: hypertension • drug therapy • prospective studies
This article has been cited by other articles:
 |
|
 |
|
  W. Putnam, F. Buhariwalla, K. Lacey, M. Goodfellow, R. A. Goodine, J. Hall, I. MacDonald, M. Murray, P. Smith, F. Burge, et al. Drug management for hypertension in type 2 diabetes in family practice Can Fam Physician, July 1, 2009; 55(7): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Houlihan, S. H. Simpson, A. J. Cave, N. W. Flook, M. E. Hurlburt, C. J. Lord, L. L. Smith, and H. H. Sternberg Hypertension treatment and control rates: Chart review in an academic family medicine clinic Can Fam Physician, July 1, 2009; 55(7): 735 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, R. D. Feldman, K. Wyard, R. Brant, N. R.C. Campbell, and for the CHEP Outcomes Research Task Force The impact of the Canadian Hypertension Education Programme in its first decade Eur. Heart J., June 2, 2009; 30(12): 1434 - 1439. [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Feldman and F. A. McAlister Postgame Wrap of the Ultimate Blood Pressure Megatrial: Did It Score an ALLHAT Trick or Was It "Three Strikes and You're Out?" Hypertension, April 1, 2009; 53(4): 595 - 597. [Full Text] [PDF]
|
|
|
|
|
|
N. R.C. Campbell, R. Brant, H. Johansen, R. L. Walker, A. Wielgosz, J. Onysko, R.-N. Gao, C. Sambell, S. Phillips, F. A. McAlister, et al. Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada Hypertension, February 1, 2009; 53(2): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mohan MD MPH and N. R.C. Campbell MD Hypertension management in Canada: good news, but important challenges remain Can. Med. Assoc. J., May 20, 2008; 178(11): 1458 - 1460. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hakim Vascular Disease: The Tsunami of Health Care Stroke, December 1, 2007; 38(12): 3296 - 3301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Onysko, C. Maxwell, M. Eliasziw, J. X. Zhang, H. Johansen, N. R.C. Campbell, and for the Canadian Hypertension Education Program Large Increases in Hypertension Diagnosis and Treatment in Canada After a Healthcare Professional Education Program Hypertension, November 1, 2006; 48(5): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Campbell and F. A. McAlister Not all guidelines are created equal. Can. Med. Assoc. J., March 14, 2006; 174(6): 814 - 815. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yang, L. D. Botto, J. D. Erickson, R. J. Berry, C. Sambell, H. Johansen, and J.M. Friedman Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002 Circulation, March 14, 2006; 113(10): 1335 - 1343. [Abstract] [Full Text] [PDF]
|
|